Company Profile
Public information reviewedDefinium Therapeutics, Inc.
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders.
USNASDAQ: DFTX
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 15
- Last reviewed
- Sep 6, 2026
Alpha Registry